Genenta Science S.p.A. (GNTA)
Nasdaq: GNTA · Biological Products, (No Diagnostic Substances) · Milan, IT · filing with the SEC since 2021
Who owns Genenta Science S.p.A.
As filed with the SECHolders of 5% or more
2
Marco Nuzzo holds 11.5% of Ordinary Shares and American Depository Shares, as its SCHEDULE 13D/A filed Oct 2, 2026 says.
Directors and officers
6
report now, of 6 people on the record since 2026. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Marco Nuzzo
SCHEDULE 13D/A · filed Oct 2, 2026 · Ordinary Shares and American Depository Shares · 23% in May 5, 2026
Pierluigi Paracchi
SCHEDULE 13G/A · filed Jan 27, 2026 · Ordinary Shares · 12.6% in Feb 10, 2025
What GNTA reports owning in othersstakes of 5% or more, and other ties
1 subsidiary in 1 country, from the list filed with the 20-F filed Mar 28, 2025.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
No open-market trade is on the record for these years.
Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.